Galway, Ireland 4th May 2023 OmniSpirant is excited to announce the appointment of Andy Fisher to its board of directors. For nearly 20 years, Andy held leadership positions at United Therapeutics Corporation, a global biotechnology [...]
PRESS RELEASE We are excited to progress the development of OS001 for CF in collaboration with Prof Lorraine Martin and Dr Lisa Douglas in Queen's University Belfast. Funding support from Emily's Entourage in the USA [...]
PRESS RELEASE OmniSpirant Limited are delighted and honoured to announce the launch of INSPIRE, a €12.8 million lung cancer project funded by Horizon Europe. In one of the largest ever grants for preclinical research in [...]
StartUs insights analysis of the global respiratory drug development landscape highlights OmniSpirant's inhaled regenerative gene therapy platform: Omnispirant explores Inhaled Gene Therapy In the last decade, advances in gene sequencing and gene editing have made [...]
Pictured from left to right: Dr Janusz Krawczyk, Dr Róisín Dwyer, Prof John Laffey, Dr Ronan MacLoughlin, Gerry McCauley, Dr Daniel O’Toole and Dr Katie Gilligan NUI Galway, OmniSpirant Limited and Aerogen Limited have [...]
OmniSpirant Limited has received funding from the European Union’s Horizon 2020 research and innovation programme under SME Instrument grant agreement 855463_ReSpire and under Horizon Europe Project 101057777_ INSPIRE
The Celtic Advanced Life Science Innovation Network (CALIN) is a 4-year Ireland-Wales INTERREG operation funded by the European Regional Development Fund through the Welsh Government.